-
18528-1A bacterial DNA gyrase inhibitor that disrupts supercoiling activity (IC<sub>50</sub> = 3.3 µM) demonstrates antibacterial activity against E. coli, P. aeruginosa, and S. enterica (MICs range from 10-80 µM).
-
18528-10A bacterial DNA gyrase inhibitor that disrupts supercoiling activity (IC<sub>50</sub> = 3.3 µM) demonstrates antibacterial activity against E. coli, P. aeruginosa, and S. enterica (MICs range from 10-80 µM).
-
18528-25A bacterial DNA gyrase inhibitor that disrupts supercoiling activity (IC<sub>50</sub> = 3.3 µM) demonstrates antibacterial activity against E. coli, P. aeruginosa, and S. enterica (MICs range from 10-80 µM).
-
18528-5A bacterial DNA gyrase inhibitor that disrupts supercoiling activity (IC<sub>50</sub> = 3.3 µM) demonstrates antibacterial activity against E. coli, P. aeruginosa, and S. enterica (MICs range from 10-80 µM).
-
16794-100An enantiomer of ibuprofen that does not inhibit COX inhibits NF-&kappaB activation (IC<sub>50</sub> = 121.8 µM) in response to T-cell stimulation blocks superoxide formation, &beta-glucuronidase release, and LTB4 generation by stimulated
-
16794-250An enantiomer of ibuprofen that does not inhibit COX inhibits NF-&kappaB activation (IC<sub>50</sub> = 121.8 µM) in response to T-cell stimulation blocks superoxide formation, &beta-glucuronidase release, and LTB4 generation by stimulated
-
16794-500An enantiomer of ibuprofen that does not inhibit COX inhibits NF-&kappaB activation (IC<sub>50</sub> = 121.8 µM) in response to T-cell stimulation blocks superoxide formation, &beta-glucuronidase release, and LTB4 generation by stimulated
-
18235-10A pure enantiomer of lansoprazole that inhibits acid formation in isolated canine parietal cells with an IC<sub>50</sub> value of 59 nM and inhibits the H+/K+-ATPase with an IC<sub>50</sub> value of 4.2 µM.
-
18235-100A pure enantiomer of lansoprazole that inhibits acid formation in isolated canine parietal cells with an IC<sub>50</sub> value of 59 nM and inhibits the H+/K+-ATPase with an IC<sub>50</sub> value of 4.2 µM.
-
18235-50A pure enantiomer of lansoprazole that inhibits acid formation in isolated canine parietal cells with an IC<sub>50</sub> value of 59 nM and inhibits the H+/K+-ATPase with an IC<sub>50</sub> value of 4.2 µM.
-
13616-1A potent inhibitor of the generation of phosphatidic acid (IC<sub>50</sub> = 0.6 µM) from cytokine-activated lysophosphatidic acyl transferase (LPAAT), which has been shown to protect mice from endotoxic shock suppresses the production of the
-
13616-10A potent inhibitor of the generation of phosphatidic acid (IC<sub>50</sub> = 0.6 µM) from cytokine-activated lysophosphatidic acyl transferase (LPAAT), which has been shown to protect mice from endotoxic shock suppresses the production of the